Novel recombinant and mutant herpesviruses
CA 2366541 C · Owner: Schering-Plough Ltd. · Inventors: Junker, David E.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides methods and reagents for inducing active immunity in animals. In particular, the present invention provides recombinant herpesviruses having foreign DNA that are capable of inducing immunity to the herpesvirus and/or the source of the foreigh DNA. The present invention also provides mutant herpesviruses having portions of their genome deleted. Preferably, foreign DNA is introduced, or portions of the genome are deleted in the UL54.5 open reading frame of avian herperviruses or the UL43 open reading frame of Marek's disease virus.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 7, 2000 and granted November 29, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 7, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 7, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.